Clinical Trials Directory

Trials / Completed

CompletedNCT01293045

Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women

Study of Change in Biological Markers of Bone Metabolism Following Consumption of Hydrolyzed Collagen for 3 Months in Healthy, Non-osteoporotic, Menopausal Women.

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
44 (actual)
Sponsor
Nealth Sarl · Network
Sex
Female
Age
55 Years – 65 Years
Healthy volunteers
Accepted

Summary

* Preliminary scientific studies, in both animals and humans suggest that oral consumption of hydrolyzed collagen acts on the bone remodeling process by stimulating the activity of osteoblasts responsible for bone formation while improving the bone mineral density and biomechanical resistance of long bones. * The objective of this clinical research is to measure changes in biomarkers of bone turnover in postmenopausal healthy women, not osteoporotic, in response to consumption of hydrolyzed collagen for three months. * For this, we propose to measure blood and urinary markers of formation and bone resorption before consumption, then 45 and 90 days after daily consumption of 10 g of hydrolyzed collagen.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENThydrolyzed collagen10g/day at breakfast during 90 days
DIETARY_SUPPLEMENTwheat protein10g/day at breakfast during 90 days

Timeline

Start date
2010-06-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2011-02-10
Last updated
2014-04-09

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01293045. Inclusion in this directory is not an endorsement.